Healthcare - Medical - Instruments & Supplies - NASDAQ - JE
$ 16.11
-2.78 %
$ 1.74 B
Market Cap
-12.49
P/E
CASH FLOW STATEMENT
-73.3 M
OPERATING CASH FLOW
184 M
INVESTING CASH FLOW
15.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
NovoCure Limited
| Net Income | -207 M |
| Depreciation & Amortization | 11 M |
| Capital Expenditures | -27.1 M |
| Stock-Based Compensation | 116 M |
| Change in Working Capital | 29.6 M |
| Others | -28.2 M |
| Free Cash Flow | -100 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (207.0) | (92.5) | (58.4) | 19.8 | (7.2) | (63.6) | (61.7) | (131.8) | (111.6) | (80.7) | (77.4) |
| Depreciation & Amortization | 11.0 | 10.6 | 10.3 | 9.2 | 8.5 | 9.0 | 7.7 | 5.7 | 3.2 | 2.0 | 1.2 |
| Deferred Income Tax | 0 | 0 | 3.9 | (0.3) | (0.5) | 0.4 | 0.2 | 5.7 | 46 K | 23 K | 19 K |
| Stock Based Compensation | 115.6 | 107.0 | 94.9 | 75.7 | 52.4 | 39.8 | 27.1 | 22.1 | 11.9 | 4.6 | 5.1 |
| Other Operating Activities | (22.4) | (6.1) | 3.0 | 3.3 | (2.2) | 1.0 | 0.3 | 0.2 | 1.0 | 19 K | 11.5 |
| Change in Working Capital | 29.6 | 11.8 | 29.1 | (8.5) | (24.3) | 11.4 | (6.8) | (9.4) | (4.4) | (0.2) | 6.8 |
| Cash From Operations | (73.3) | 30.8 | 82.8 | 99.1 | 26.6 | (1.9) | (33.1) | (107.6) | (99.9) | (74.2) | (52.7) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (27.1) | (21.4) | (24.2) | (15.0) | (10.5) | (6.7) | (7.4) | (17.7) | (10.3) | (2.3) | (3.6) |
| Other Items | 211.2 | (118.6) | (120.7) | (457.9) | (41.2) | 1.2 | 14.1 | 30.5 | (105.0) | (43.9) | 14.0 |
| Cash From Investing Activities | 184.1 | (140.0) | (144.8) | (472.8) | (51.7) | (5.5) | 6.8 | 12.8 | (115.3) | (46.2) | 10.4 |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 K | 0 | 0 |
| Total Debt Repaid | 10 K | 28 K | 26 K | 408.4 | 31 K | 49.1 | 57 K | 72.8 | 22.8 | 9 K | (8.4) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 11.4 | 10.3 | 21.2 | 28.4 | 59.2 | 18.5 | 3.7 | 1.7 | 2.0 | 2.2 | 2 K |
| Cash From Financing Activities | 15.8 | 15.5 | 25.7 | 440.2 | 61.7 | 69.4 | 5.2 | 75.1 | 277.0 | 2.1 | 183.3 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 126.7 | (93.8) | (36.6) | 66.8 | 36.7 | 62.0 | (21.2) | (19.6) | 61.8 | (118.3) | 141.0 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (100.4) | 9.4 | 58.6 | 84.2 | 16.1 | (8.6) | (40.5) | (125.3) | (110.2) | (76.6) | (56.3) |